Skip to content

Effects of chitosan oligosaccharides supplements on serum lipid and body composition in overweight and obese Thai women

Effects of chitosan oligosaccharides supplements on serum lipid and body composition in overweight and obese Thai women

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
TCTR
Registry ID
TCTR20250625005
Enrollment
56
Registered
2025-06-25
Start date
2021-03-08
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thai women are overweight and obese, aged between 30 to 59 years, and with high total cholesterol or LDL cholesterol. Chito-oligosaccharides, Obesity, Overweight, Serum lipid, Thai women.

Interventions

Sponsors

Mahidol University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
30 Years to 59 Years

Inclusion criteria

Inclusion criteria: The inclusion criteria were as follows: 1) Thai women with a BMI more than or equal to 23 kg/m2; 2) waist circumference more than or equal to 80 cm; 3) age between 30 to 59 years; 4) total cholesterol level more than 200 mg/dL or LDL-C level more than 130 mg/dL; and 5) capable of taking food photos and use the LINE application to send information. All participants were requested to provide blood samples for the analysis of lipid profiles and the results had to pass the specific criteria.

Exclusion criteria

Exclusion criteria: 1) a history of metabolic syndrome, hepatic, renal, autoimmune, gastrointestinal, or neurological diseases; 2) current or recently consumed food supplements, over-the-counter (OTC) products, and/or pharmaceutical agents that might influence the outcome of this study (e.g., Orlistat); 3) current or recent history of eating disorders, bipolar disorder, or severe depression; 4) pregnancy or lactation; 5) allergies or intolerance to crustaceans and/or seafood products; 6) vegetarian dietary preferences; 7) current COVID-19 patients; 8) recovery from COVID-19 within the past 3 months; and 9) individuals judged to be unlikely to comply with the study treatment and follow-up procedures.

Design outcomes

Primary

MeasureTime frame
LDL at 60 days after end of the intervention Friedwald equation,total cholesterol at 60 days after end of the intervention enzymatic colorimetric tests

Secondary

MeasureTime frame
Body weight at 60 days after end of the intervention calibrated digital scales ,Waist and hip circumference at 60 days after end of the intervention non-stretch tape measure on lightly clad participants

Countries

Thailand

Contacts

Public ContactNatnaree Mayang

Mahidol University

Natnaree.nik@gmail.com0876594824

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026